Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Research article

Summary adherence estimates do not portray the true incongruity between drug intake, nurse documentation and physicians’ orders

Authors: Inbal Cohen-Glickman, Yosef S Haviv, Matan J Cohen

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

Hemodialysis patients (HD) need to adhere to a complex medication regimen. Because their daily pill burden is one of the highest reported, poor compliance is a major cause of therapeutic failure. The primary aim of this study was to define patterns of medication prescription, intake and documentation among HD patients.

Methods

HD patients treated between 2007 and 2009 and assigned to the largest health service provider in Israel were randomly selected. Drug practices were abstracted from their records and compared to electronic pharmacy data. The discrepancy between drug intake reports and the actual purchase was measured to estimate adherence. Drug purchase, intake report and physician order were plotted in complementing diagrams to appreciate consistency and discrepancy patterns.

Results

The study included full analysis of 75 patients. The mean overall drug adherence was 56.7% (95% CI 53.6-59.9%), varying among drug families and over time. Often, there was a systematic disengagement between the nurses’ documentation and the actual patient purchase. Specifically, we observed either different quantities of medication use, improper documentation of a non-purchased drug, drug purchase without nurse documentation and futile physician attempts to modify prescriptions of unpurchased medication. We found a high rate of physician order turbulence for active vitamin D and calcium.

Conclusions

Drug prescription, documentation and adherence are incongruent and their mismatches are diverse. Summary estimates do not divulge the extent of these disparities. These system-wide communication failures compromise patient care. Strategies to promote system reconciliation and reasonable medication prescription are in need.
Appendix
Available only for authorised users
Literature
1.
go back to reference Burkhart PV, Sabaté E: Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003, 35 (3): 207-PubMed Burkhart PV, Sabaté E: Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003, 35 (3): 207-PubMed
2.
go back to reference Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R: Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009, 4 (6): 1089-1096. 10.2215/CJN.00290109.CrossRefPubMedPubMedCentral Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R: Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009, 4 (6): 1089-1096. 10.2215/CJN.00290109.CrossRefPubMedPubMedCentral
3.
go back to reference Pai AB, Cardone KE, Manley HJ, St Peter WL, Shaffer R, Somers M, Mehrotra R: Nephrology DAGoASo: Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach. Clin J Am Soc Nephrol. 2013, 8 (11): 1988-1999. 10.2215/CJN.01420213.CrossRefPubMedPubMedCentral Pai AB, Cardone KE, Manley HJ, St Peter WL, Shaffer R, Somers M, Mehrotra R: Nephrology DAGoASo: Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach. Clin J Am Soc Nephrol. 2013, 8 (11): 1988-1999. 10.2215/CJN.01420213.CrossRefPubMedPubMedCentral
4.
go back to reference U.S. Renal Data System, USRDS: Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2013, Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases U.S. Renal Data System, USRDS: Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2013, Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
5.
go back to reference Matteson ML, Russell C: Interventions to improve hemodialysis adherence: a systematic review of randomized-controlled trials. Hemodial Int. 2010, 14 (4): 370-382. 10.1111/j.1542-4758.2010.00462.x.CrossRefPubMed Matteson ML, Russell C: Interventions to improve hemodialysis adherence: a systematic review of randomized-controlled trials. Hemodial Int. 2010, 14 (4): 370-382. 10.1111/j.1542-4758.2010.00462.x.CrossRefPubMed
6.
go back to reference Saran R, Bragg-Gresham JL, Rayner HC, Goodkin DA, Keen ML, Van Dijk PC, Kurokawa K, Piera L, Saito A, Fukuhara S, Young EW, Held PJ Port FK: Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int. 2003, 64 (1): 254-262. 10.1046/j.1523-1755.2003.00064.x.CrossRefPubMed Saran R, Bragg-Gresham JL, Rayner HC, Goodkin DA, Keen ML, Van Dijk PC, Kurokawa K, Piera L, Saito A, Fukuhara S, Young EW, Held PJ Port FK: Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int. 2003, 64 (1): 254-262. 10.1046/j.1523-1755.2003.00064.x.CrossRefPubMed
7.
go back to reference Bame SI, Petersen N, Wray NP: Variation in hemodialysis patient compliance according to demographic characteristics. Soc Sci Med. 1993, 37 (8): 1035-1043. 10.1016/0277-9536(93)90438-A.CrossRefPubMed Bame SI, Petersen N, Wray NP: Variation in hemodialysis patient compliance according to demographic characteristics. Soc Sci Med. 1993, 37 (8): 1035-1043. 10.1016/0277-9536(93)90438-A.CrossRefPubMed
8.
go back to reference Karamanidou C, Clatworthy J, Weinman J, Horne R: A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol. 2008, 9: 2-10.1186/1471-2369-9-2.CrossRefPubMedPubMedCentral Karamanidou C, Clatworthy J, Weinman J, Horne R: A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol. 2008, 9: 2-10.1186/1471-2369-9-2.CrossRefPubMedPubMedCentral
9.
go back to reference Loghman-Adham M: Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation. Am J Manag Care. 2003, 9 (2): 155-171.PubMed Loghman-Adham M: Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation. Am J Manag Care. 2003, 9 (2): 155-171.PubMed
10.
go back to reference Andrade SE, Kahler KH, Frech F, Chan KA: Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006, 15 (8): 565-574. 10.1002/pds.1230. discussion 575–567CrossRefPubMed Andrade SE, Kahler KH, Frech F, Chan KA: Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006, 15 (8): 565-574. 10.1002/pds.1230. discussion 575–567CrossRefPubMed
11.
go back to reference Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD: Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ. 1999, 160 (1): 41-46.PubMedPubMedCentral Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD: Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ. 1999, 160 (1): 41-46.PubMedPubMedCentral
12.
go back to reference Friedman EA: Hemodialysis prescription and life expectancy. J Am Soc Nephrol. 1994, 4 (9): 1733-PubMed Friedman EA: Hemodialysis prescription and life expectancy. J Am Soc Nephrol. 1994, 4 (9): 1733-PubMed
13.
go back to reference Kaveh K, Kimmel PL: Compliance in hemodialysis patients: multidimensional measures in search of a gold standard. Am J Kidney Dis. 2001, 37 (2): 244-266. 10.1053/ajkd.2001.21286.CrossRefPubMed Kaveh K, Kimmel PL: Compliance in hemodialysis patients: multidimensional measures in search of a gold standard. Am J Kidney Dis. 2001, 37 (2): 244-266. 10.1053/ajkd.2001.21286.CrossRefPubMed
14.
go back to reference Hess LM, Raebel MA, Conner DA, Malone DC: Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006, 40 (7–8): 1280-1288.CrossRefPubMed Hess LM, Raebel MA, Conner DA, Malone DC: Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006, 40 (7–8): 1280-1288.CrossRefPubMed
15.
go back to reference Vollmer WM, Xu M, Feldstein A, Smith D, Waterbury A, Rand C: Comparison of pharmacy-based measures of medication adherence. BMC Health Serv Res. 2012, 12: 155-10.1186/1472-6963-12-155.CrossRefPubMedPubMedCentral Vollmer WM, Xu M, Feldstein A, Smith D, Waterbury A, Rand C: Comparison of pharmacy-based measures of medication adherence. BMC Health Serv Res. 2012, 12: 155-10.1186/1472-6963-12-155.CrossRefPubMedPubMedCentral
16.
go back to reference Curtin RB, Svarstad BL, Keller TH: Hemodialysis patients’ noncompliance with oral medications. ANNA J/Am Nephrol Nurses’ Assoc. 1999, 26 (3): 307-316. discussion 317, 335 Curtin RB, Svarstad BL, Keller TH: Hemodialysis patients’ noncompliance with oral medications. ANNA J/Am Nephrol Nurses’ Assoc. 1999, 26 (3): 307-316. discussion 317, 335
17.
go back to reference Farmer KC: Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999, 21 (6): 1074-1090. 10.1016/S0149-2918(99)80026-5. discussion 1073CrossRefPubMed Farmer KC: Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999, 21 (6): 1074-1090. 10.1016/S0149-2918(99)80026-5. discussion 1073CrossRefPubMed
18.
go back to reference Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997, 50 (1): 105-116. 10.1016/S0895-4356(96)00268-5.CrossRefPubMed Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997, 50 (1): 105-116. 10.1016/S0895-4356(96)00268-5.CrossRefPubMed
19.
go back to reference Manley HJ, Drayer DK, McClaran M, Bender W, Muther RS: Drug record discrepancies in an outpatient electronic medical record: frequency, type, and potential impact on patient care at a hemodialysis center. Pharmacotherapy. 2003, 23 (2): 231-239. 10.1592/phco.23.2.231.32079.CrossRefPubMed Manley HJ, Drayer DK, McClaran M, Bender W, Muther RS: Drug record discrepancies in an outpatient electronic medical record: frequency, type, and potential impact on patient care at a hemodialysis center. Pharmacotherapy. 2003, 23 (2): 231-239. 10.1592/phco.23.2.231.32079.CrossRefPubMed
20.
go back to reference Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD, for the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002, 347 (23): 1825-1833.CrossRefPubMed Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD, for the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002, 347 (23): 1825-1833.CrossRefPubMed
21.
go back to reference Parker JD, Parker JO: Nitrate therapy for stable angina pectoris. N Engl J Med. 1998, 338 (8): 520-531. 10.1056/NEJM199802193380807.CrossRefPubMed Parker JD, Parker JO: Nitrate therapy for stable angina pectoris. N Engl J Med. 1998, 338 (8): 520-531. 10.1056/NEJM199802193380807.CrossRefPubMed
22.
go back to reference MacDonald R, Wilt TJ, Howe RW: Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects. BJU Int. 2004, 94 (9): 1263-1270. 10.1111/j.1464-410X.2004.05154.x.CrossRefPubMed MacDonald R, Wilt TJ, Howe RW: Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects. BJU Int. 2004, 94 (9): 1263-1270. 10.1111/j.1464-410X.2004.05154.x.CrossRefPubMed
23.
go back to reference Manley HJ, Garvin CG, Drayer DK, Reid GM, Bender WL, Neufeld TK, Hebbar S, Muther RS: Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol Dial Transplant. 2004, 19 (7): 1842-1848. 10.1093/ndt/gfh280.CrossRefPubMed Manley HJ, Garvin CG, Drayer DK, Reid GM, Bender WL, Neufeld TK, Hebbar S, Muther RS: Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol Dial Transplant. 2004, 19 (7): 1842-1848. 10.1093/ndt/gfh280.CrossRefPubMed
24.
go back to reference Mason NA: Polypharmacy and medication-related complications in the chronic kidney disease patient. Curr Opin Nephrol Hypertens. 2011, 20 (5): 492-497. 10.1097/MNH.0b013e328349c261.CrossRefPubMed Mason NA: Polypharmacy and medication-related complications in the chronic kidney disease patient. Curr Opin Nephrol Hypertens. 2011, 20 (5): 492-497. 10.1097/MNH.0b013e328349c261.CrossRefPubMed
25.
go back to reference Manley HJ, Bailie GR, Grabe DW: Comparing medication use in two hemodialysis units against national dialysis databases. Am J Health Syst Pharm. 2000, 57 (9): 902-906.PubMed Manley HJ, Bailie GR, Grabe DW: Comparing medication use in two hemodialysis units against national dialysis databases. Am J Health Syst Pharm. 2000, 57 (9): 902-906.PubMed
Metadata
Title
Summary adherence estimates do not portray the true incongruity between drug intake, nurse documentation and physicians’ orders
Authors
Inbal Cohen-Glickman
Yosef S Haviv
Matan J Cohen
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-170

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.